A retrospective cohort study published July 19, 2026, in Acta Obstetricia et Gynecologica Scandinavica found that women with endometriosis have threefold higher odds of treatment failure and recurrence when hospitalized for pelvic inflammatory disease (PID), alongside longer average hospital stays.
For years, endometriosis has been categorized primarily as a reproductive disorder. However, new data suggests a more complex relationship between this condition and acute pelvic infections. In a study led by Marta Camacho at the Hospital Clinic of Barcelona, researchers tracked 159 women hospitalized for pelvic inflammatory disease between 2018 and 2023 to determine if the presence of endometriosis altered clinical outcomes.
Threefold Increase in Treatment Failure and Recurrence
The findings reveal a stark contrast in how patients fare based on their endometriosis status. After multivariate adjustment, endometriosis was associated with threefold higher odds of both treatment failure and the recurrence of PID.
Treatment failure was specifically defined as a lack of clinical improvement or actual deterioration within 48 to 72 hours following admission. Recurrence was marked by a new episode of PID requiring hospitalization at least 30 days after the patient was discharged. Beyond these risks, women with endometriosis spent an average of 1.7 additional days in the hospital.
Interestingly, the data did not show a significant association between endometriosis and the immediate need for surgery during the hospital stay.
The Role of Non-STD Pathogens and Disease Subtypes
One of the most revealing aspects of the Barcelona study is the disconnect between endometriosis and sexually transmitted diseases (STDs). While 42.3% of patients without endometriosis tested positive for an STD, only 2.1% of those with endometriosis did.
This suggests that the PID episodes in women with endometriosis may be driven by different triggers. This shift in pathology has direct implications for how doctors treat these patients. Because the standard empirical antibiotic regimens often target STDs, the authors suggest that regimens may require modification to more effectively cover non-STD pathogens.
- Ovarian endometrioma: The most common subtype, identified in 72.9% of women.
- Deep endometriosis: Confirmed in 64.5% of patients via follow-up imaging.
While a subgroup analysis indicated that women with deep endometriosis experienced higher rates of recurrence and treatment failure than those without the deep form, those specific differences did not reach statistical significance.
Endometriosis as a Systemic Whole-Body Disorder
The link between endometriosis and worsened PID outcomes aligns with a broader medical shift in how the disease is understood. According to sources, experts are increasingly proposing that endometriosis is a systemic condition rather than a localized reproductive issue.
This systemic view posits that chronic inflammation, immune responses, and hormonal imbalances associated with the disease can influence multiple organs. Patients often report symptoms far beyond pelvic pain, including fatigue, neurological symptoms, and digestive issues like bloating. This systemic inflammation may explain why the body struggles more effectively to resolve acute pelvic infections like PID.
Surgical Challenges and Colorectal Involvement
When endometriosis progresses to its deep infiltrating form, the stakes for surgical intervention rise. As noted in the sources, this version of the disease frequently involves the rectovaginal septum, sigmoid colon, and rectum. This complexity has shifted the management of the disease further into the domain of colorectal surgery.
Surgeons are currently working to standardize the balance between symptom relief and the preservation of bowel function and fertility. Current debates in the field center on comparing different operative modalities, such as shaving, discoid excision, and segmental resection techniques.
The use of robotic and minimally invasive techniques has expanded, but the evidence base for colorectal interventions remains fragmented, leaving a gap in international consensus on postoperative care and the risk of recurrence.
Clinical Implications for High-Risk Patients
The intersection of these findings suggests a need for a more personalized approach to pelvic health. For women with known endometriosis, a PID diagnosis is not a standard event; it is a high-risk scenario with a higher likelihood of hospital readmission and a slower recovery trajectory.
The Barcelona researchers emphasize that admission criteria should be adjusted to account for longer expected stays and that communication with patients must be clear and reassuring. Because the diagnosis in the study was based on transvaginal ultrasound rather than histologic confirmation, there remains a possibility of diagnostic misclassification. Furthermore, because the study only included hospitalized patients, it is unclear if these outcomes apply to women with mild PID managed in outpatient settings.
The central uncertainty remaining is whether the increased treatment failure is a result of the underlying systemic inflammation of endometriosis or if the physical adhesions and scar tissue caused by the disease simply make the pelvic environment more susceptible to persistent infection.
Worth a look
